Meta To Rally Around 8%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see ouranalyst ratings page.Morgan Stanley raisedRobinhood Markets, Inc.HOODprice target from $43 to $110. Morgan Stanley analyst Michael Cyprys maintained an Equal-Weight rating. Robinhood shares closed at $99.96 on Monday.See how other analysts view this stock.Barclays cut the price target forAlibaba Group Holding LimitedBABAfrom $180 to $145. Barclays analyst Jiong Shao maintained an Overweight rating. Alibaba shares closed at $108.22 on Monday. See how other analystsview this stock.Wells Fargo cutWaters CorporationWATprice target from $420 to $330. Wells Fargo analyst Brandon Couillard downgraded the stock from Overweight to Equal-Weight. Waters shares closed at $304.18 on Monday.See how other analysts view this stock.Keybanc boosted the price target forLam Research CorporationLRCXfrom $105 to $115. Keybanc analyst Steve Barger maintained an Overweight rating. Lam Research shares closed at $99.62 on Monday.See how other analysts view this stock.UBS cut the price target forOscar Health, Inc.OSCRfrom $15 to $11. UBS analyst Jonathan Yong downgraded the stock from Neutral to Sell. Oscar Health shares closed at $15.08 on Monday. See how other analystsview this stock.JMP Securities raisedDoorDash, Inc.DASHprice target from $235 to $250. JMP Securities analyst Andrew Boone maintained a Market Outperform rating. DoorDash shares settled at $242.85 on Monday.See how other analysts view this stock.B of A Securities increasedMeta Platforms, Inc.METAprice target from $765 to $775. B of A Securities analyst Justin Post maintained a Buy rating. Meta shares closed at $720.92 on Monday.See how other analysts view this stock.Stephens & Co. raisedFastenal CompanyFASTprice target from $40 to $45. Stephens & Co. analyst Tommy Moll maintained an Equal-Weight rating. Fastenal shares closed at $45.07 on Monday.See how other analysts view this stock.JP Morgan raised the price target forCalifornia Resources CorporationCRCfrom $60 to $63. JP Morgan analyst Zach Parham upgraded the stock from Neutral to Overweight. California Resources shares settled at $47.60 on Monday.See how other analysts view this stock.Morgan Stanley increasedAbbott LaboratoriesABTprice target from $127 to $137. Morgan Stanley analyst David Lewis maintained an Equal-Weight rating. Abbott shares closed at $132.03 on Monday.See how other analysts view this stock.Considering buying META stock? Here’s what analysts think:Trending Investment OpportunitiesAdvertisementArrivedBuy shares of homes and vacation rentals for as little as $100.Get StartedWiserAdvisorGet matched with a trusted, local financial advisor for free.Get StartedPoint.comTap into your home's equity to consolidate debt or fund a renovation.Get StartedRobinhoodMove your 401k to Robinhood and get a 3% match on deposits.Get StartedRead This Next:JPMorgan, Wells Fargo And 3 Stocks To Watch Heading Into TuesdayPhoto via ShutterstockLoading...Loading...ABTAbbott Laboratories$131.52-0.39%Stock Score Locked: Want to See it?Benzinga Rankings give you vital metrics on any stock – anytime.Reveal Full ScoreEdge RankingsMomentum80.15Growth99.11Quality61.68Value46.17Price TrendShortMediumLongOverviewBABAAlibaba Group Holding Ltd$114.956.22%CRCCalifornia Resources Corp$48.291.45%DASHDoorDash Inc$240.50-0.97%FASTFastenal Co$45.100.07%HOODRobinhood Markets Inc$99.12-0.84%LRCXLam Research Corp$101.191.58%METAMeta Platforms Inc$724.140.45%OSCROscar Health Inc$14.90-1.19%WATWaters Corp$307.000.93%Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. . .EarningsAnalyst RatingsOptionsDividendsIPOsdate▲▼ticker▲▼name▲▼Price Target▲▼Upside/Downside▲▼Recommendation▲▼Firm▲▼Click to see moreAnalyst RatingsupdatesAnalyst CalendarJoin Benzinga Edge and unlock all the major upgrades, downgrades, and changes to the market's most accurate analysts.Click to JoinPosted In:NewsPrice TargetPre-Market OutlookMarketsAnalyst RatingsTrading Ideasanalysts forecastsPT Changes